Год
2023
-
Australian scientists closer to finding new lung cancer treatments
-
Phase 3 clinical trial of ambroxol for Parkinson’s confirmed
-
Title: US FDA Approves AstraZeneca-Avillion’s Asthma Treatment Airsupra: A Step Forward for Asthma Patients
-
FDA rejects Biocon insulin biosimilar over data, manufacturing concerns
-
Bayer taps Google’s quantum power for drug discovery
-
FDA Approves FoundationOne Liquid CDx to Identify Genomic Profile in NSCLC
-
Roche’s Lunsumio Gets Accelerated Approval for Later-Line Follicular Lymphoma
-
FDA Grants Priority Review to Roche’s Glofitamab BLA in Large B-Cell Lymphoma
-
ACELYRIN acquires ValenzaBio, strengthens immunology position
-
FDA Approves Briumvi for Relapsing Multiple